Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies

Pricing and reimbursement strategies for innovative new drugs require significant evidence of beneficial clinical and economic outcomes using cost effectiveness and budget impact models.

• Pharmaceutical Pricing and Reimbursement (13/05/2008)

• The Anti-Infectives Market Outlook to 2013 (14/10/2008)
• Respiratory Disorders (14/10/2008)
• Monoclonal Antibodies Report (14/10/2008)
• EU Pharmaceutical Forum (11/10/2008)
• Neuropathic Pain (10/10/2008)
• Non-hormonal Treatments for Menopausal Symptoms (10/10/2008)
• Rx-to-OTC Strategies (10/10/2008)
• Asthma (10/10/2008)
• Vaccines for Adults and the Elderly (10/10/2008)

---